| Citation: |
MAO Tingting, JIANG Qiong, WANG Yan, MING Xia, LOU Yinghua. Correlations of serum transforming growth factor-β1 and insulin-like growth factor-1 with pathological features and postoperative recurrence in patients with adenomyosis[J]. Journal of Clinical Medicine in Practice, 2025, 29(4): 103-107. DOI: 10.7619/jcmp.20243572
|
To investigate the correlations of expression levels of serum transforming growth factor-β1 (TGF-β1) and insulin-like growth factor-1 (IGF-1) with clinicopathological features of patients with adenomyosis, and the clinical value of their prediction of postoperative recurrence.
Eighty-two patients with adenomyosis were selected as study subjects (study group). Patients were followed up for two years after surgery and divided into recurrence group (n=15) and non-recurrence group (n=67) based on their postoperative status. An additional 85 healthy individuals who underwent physical examinations during the same period were selected as control group. Serum TGF-β1 and IGF-1 levels were compared between the study group and the control group. The correlations of serum TGF-β1 and IGF-1 levels with the clinicopathological characteristics of adenomyosis patients was analyzed. Serum TGF-β1 and IGF-1 levels were compared between the recurrence and non-recurrence groups. Receiver operating characteristic (ROC) curve analysis was used to evaluate the diagnostic efficacy of serum TGF-β1 and IGF-1 levels in predicting postoperative recurrence in adenomyosis patients.
Serum TGF-β1 and IGF-1 levels in the study group were significantly higher than those in the control group (P < 0.05). Serum TGF-β1 levels were correlated with menstrual volume, history of curettage, uterine volume, pathological type, lesion volume, endometrial status and ectopic gland cycle (P < 0.05). Serum IGF-1 levels were correlated with menstrual volume, history of curettage, uterine volume, pathological type, endometrial status and ectopic gland cycle (P < 0.05). Postoperative serum TGF-β1 and IGF-1 levels in the recurrence group were significantly higher than those in the non-recurrence group (P < 0.05). ROC curve analysis showed that the area under the curve (AUC) for predicting postoperative recurrence using serum TGF-β1, IGF-1 and their combination were 0.823, 0.803 and 0.940, respectively. The clinical efficacy of TGF-β1 and IGF-1 in combination in predicting postoperative recurrence was superior to that of TGF-β1 alone (Zcombined with TGF-β1=2.001, Zcombined with IGF-1=2.318, P=0.045, 0.021).
The serum levels of TGF-β1 and IGF-1 in patients with adenomyosis are significantly increased, which are closely related to the clinicopathological features of the patients. The combination of serum TGF-β1 and IGF-1 levels has high clinical efficacy in predicting postoperative recurrence.
| [1] |
LIU F, LIU L X, ZHENG J. Expression of annexin A2 in adenomyosis and dysmenorrhea[J]. Arch Gynecol Obstet, 2019, 300(3): 711-716. doi: 10.1007/s00404-019-05205-w
|
| [2] |
郭玲玲, 郑娟, 汪美香. 腹腔镜手术联合GnRH-a治疗子宫腺肌症的疗效及对患者PGF2α、PGE2及β-内啡肽的影响[J]. 中国妇幼保健, 2020, 35(2): 369-371.
|
| [3] |
王敏, 邢培凯. 血清VEGF、HE4水平与年轻子宫腺肌症患者术后复发的关系[J]. 医药论坛杂志, 2022, 43(6): 24-26, 31.
|
| [4] |
ZHAO J Y, CHEN Q, CAI D G, et al. Dominant factors affecting reproductive outcomes of fertility-desiring young women with intrauterine adhesions[J]. Arch Gynecol Obstet, 2017, 295(4): 923-927. doi: 10.1007/s00404-017-4314-z
|
| [5] |
ABUDUKEYOUMU A, LI M Q, XIE F. Transforming growth factor-β1 in intrauterine adhesion[J]. Am J Reprod Immunol, 2020, 84(2): e13262. doi: 10.1111/aji.13262
|
| [6] |
DORIA P L S, MOSCOVITZ T, TCHERNIAKOVSKY M, et al. Association of IGF-1 CA(n) and IGFBP3 rs2854746 polymorphisms with endometrial polyp risk[J]. Biomed Res Int, 2018, 2018: 8704346.
|
| [7] |
沈铿, 马丁. 妇产科学[M]. 3版. 北京: 人民卫生出版社, 2015: 363-364.
|
| [8] |
中国医师协会妇产科医师分会子宫内膜异位症专业委员会. 子宫腺肌病诊治中国专家共识[J]. 中华妇产科杂志, 2020, 55(6): 376-383.
|
| [9] |
UPSON K, MISSMER S A. Epidemiology of adenomyosis[J]. Semin Reprod Med, 2020, 38(2/3): 89-107.
|
| [10] |
丁其培, 卢红, 陆月梅, 等. 内质网应激相关因子氧调节蛋白150在子宫腺肌症中的表达及临床意义[J]. 中外医学研究, 2023, 21(7): 66-69.
|
| [11] |
VANNUCCINI S, PETRAGLIA F. Recent advances in understanding and managing adenomyosis[J]. F1000Res, 2019, 8: F1000FacultyRev-F1000Faculty283.
|
| [12] |
楚贺敏, 贺全勤, 杨蕾. 曼月乐联合GnR H-a对子宫腺肌症患者术后子宫体积、血清HE4水平及月经血量的影响[J]. 中国计划生育学杂志, 2023, 31(1): 32-36.
|
| [13] |
NIJKANG N P, ANDERSON L, MARKHAM R, et al. Endometrial polyps: pathogenesis, sequelae and treatment[J]. SAGE Open Med, 2019, 7: 2050312119848247.
|
| [14] |
FARAJI A, SHAMSADINIMOGHADAM R, JAHROMI M A, et al. TGF-β1 role in uterine leiomyoma and endometrial polyp: an insight to drug-based treatment instead of surgical techniques[J]. Obstet Gynecol Sci, 2021, 64(1): 107-113.
|
| [15] |
ZHOU W J, YANG H L, SHAO J, et al. Anti-inflammatory cytokines in endometriosis[J]. Cell Mol Life Sci, 2019, 76(11): 2111-2132.
|
| [16] |
CHEONG M L, LAI T H, WU W B. Connective tissue growth factor mediates transforming growth factor β-induced collagen expression in human endometrial stromal cells[J]. PLoS One, 2019, 14(1): e0210765.
|
| [17] |
吴会娜, 段晓怡, 吕田甜. 血清转化生长因子-β1、血管内皮生长因子对子宫内膜息肉患者宫腔镜术后复发的影响[J]. 河南医学研究, 2021, 30(33): 6214-6217.
|
| [18] |
ZHANG S W, LI P P, YUAN Z W, et al. Platelet-rich plasma improves therapeutic effects of menstrual blood-derived stromal cells in rat model of intrauterine adhesion[J]. Stem Cell Res Ther, 2019, 10(1): 61.
|
| [19] |
HEIDARI S, KOLAHDOUZ-MOHAMMADI R, KHODAVERDI S, et al. Expression levels of MCP-1, HGF, and IGF-1 in endometriotic patients compared with non-endometriotic controls[J]. BMC Womens Health, 2021, 21(1): 422.
|
| [20] |
ZHAI J Y, LI S, SEN S, et al. m6A RNA methylation regulators contribute to eutopic endometrium and myometrium dysfunction in adenomyosis[J]. Front Genet, 2020, 11: 716.
|
| [21] |
费婷婷, 徐鸣, 俞剑娣, 等. 血清HSP90A、STIP-1和IGF-1检测对子宫腺肌病的临床诊断价值[J]. 检验医学与临床, 2023, 20(7): 940-944.
|
© 2020 《实用临床医药杂志》编辑部
Address: 江苏省扬州市江阳中路136号，扬州大学江阳路北校区14号楼201室China Pos: 225009Tel: 0514-87978917、87978989、87978807
Supported by:
Beijing Renhe Information Technology Co., Ltd.
苏公网安备 32100302010246号
DownLoad: